{
  "id": [
    "PMC7269953"
  ],
  "source": [
    "PMC"
  ],
  "pmcid": [
    "PMC7269953"
  ],
  "doi": [
    "10.1016/j.ejca.2020.05.026"
  ],
  "title": [
    "Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019."
  ],
  "authorString": [
    "Di Cosimo S, Malfettone A, Pérez-García JM, Llombart-Cussac A, Miceli R, Curigliano G, Cortés J."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Di Cosimo S"
          ],
          "firstName": [
            "Serena"
          ],
          "lastName": [
            "Di Cosimo"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy"
              ]
            }
          ]
        },
        {
          "fullName": [
            "Malfettone A"
          ],
          "firstName": [
            "Andrea"
          ],
          "lastName": [
            "Malfettone"
          ],
          "initials": [
            "A"
          ]
        },
        {
          "fullName": [
            "Pérez-García JM"
          ],
          "firstName": [
            "José M."
          ],
          "lastName": [
            "Pérez-García"
          ],
          "initials": [
            "JM"
          ]
        },
        {
          "fullName": [
            "Llombart-Cussac A"
          ],
          "firstName": [
            "Antonio"
          ],
          "lastName": [
            "Llombart-Cussac"
          ],
          "initials": [
            "A"
          ]
        },
        {
          "fullName": [
            "Miceli R"
          ],
          "firstName": [
            "Rosalba"
          ],
          "lastName": [
            "Miceli"
          ],
          "initials": [
            "R"
          ]
        },
        {
          "fullName": [
            "Curigliano G"
          ],
          "firstName": [
            "Giuseppe"
          ],
          "lastName": [
            "Curigliano"
          ],
          "initials": [
            "G"
          ]
        },
        {
          "fullName": [
            "Cortés J"
          ],
          "firstName": [
            "Javier"
          ],
          "lastName": [
            "Cortés"
          ],
          "initials": [
            "J"
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "135"
      ],
      "journalIssueId": [
        "2967180"
      ],
      "dateOfPublication": [
        "2020 Aug"
      ],
      "monthOfPublication": [
        "8"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-08-01"
      ],
      "journal": [
        {
          "title": [
            "European Journal of Cancer"
          ],
          "ISOAbbreviation": [
            "Eur J Cancer"
          ],
          "medlineAbbreviation": [
            "Eur J Cancer"
          ],
          "NLMid": [
            "0074126"
          ],
          "ISSN": [
            "0959-8049"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "62-65"
  ],
  "abstractText": [
    "Highlights•Patients with severe coronavirus disease 2019 (COVID-19) present with lymphocytopenia and T-cell exhaustion.•Persistent stimulation by severe acute respiratory syndrome coronavirus 2 leads to the inhibition of the immune system.•Immune blockade in patients with cancer supports host protective immunity.•Immune checkpoint inhibitors safely restore immunocompetence in sepsis and viral infections.•Immunostimulants should be considered as the first-line option in severe COVID-19."
  ],
  "affiliation": [
    "Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Undetermined"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Tocilizumab",
        "Cytokine Storm",
        "Anti–pd-1",
        "Pembrolizumab",
        "Covid-19",
        "Sars-cov-2",
        "Anti–il-6r"
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "PubMedCentral"
          ],
          "url": [
            "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269953/?tool=EBI"
          ]
        },
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7269953"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.ejca.2020.05.026"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "Y"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "N"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCreation": [
    "2020-06-07"
  ],
  "firstIndexDate": [
    "2020-06-07"
  ],
  "fullTextReceivedDate": [
    "2020-06-07"
  ],
  "dateOfRevision": [
    "2020-06-15"
  ],
  "electronicPublicationDate": [
    "2020-06-04"
  ],
  "firstPublicationDate": [
    "2020-06-07"
  ]
}